Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingtian Xu

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Critical Reviews in Oncology/Hematology|February 9, 2026
The Critical Role of Epithelial-Mesenchymal Transition (EMT) in Colorectal Cancer Progression and Therapeutic OutcomesHailang Jiang, Bingtian Xu
International Journal of Biological Sciences|November 13, 2018
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic strokeHaitao Wang, Uma Gaur, Jiao Xiao, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 25, 2025
OAC1 improves mitofusin 2 expression to alleviate neuronal injury following experimental ischemic strokeYuanyuan Wang, Kechun Chen, Bingtian Xu, et al.
Glia|May 24, 2024
Inhibition of phosphodiesterase 4 attenuates aquaporin 4 expression and astrocyte swelling following cerebral ischemia/reperfusion injuryKechun Chen, Bingtian Xu, Shuqin Qiu, et al.
Free Radical Biology & Medicine|December 28, 2020
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathwayBingtian Xu, Jiangping Xu, Ningbo Cai, et al.
European Journal of Pharmacology|May 15, 2022
Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathwayNingbo Cai, Bingtian Xu, Xing Li, et al.
Cellular and Molecular Neurobiology|October 30, 2019
Inhibition of PDE4 Attenuates TNF-α-Triggered Cell Death Through Suppressing NF-κB and JNK Activation in HT-22 Neuronal CellsJiao Xiao, Rumeng Yao, Bingtian Xu, et al.
Cell Death and Differentiation|March 3, 2026
ACSL4-mediated astrocyte ferroptosis augments neuroinflammation and exacerbates NMOSD pathologyHaixia Wen, Yinyu Zi, Zhuhe Liu, et al.
Molecular Neurobiology|September 17, 2024
Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/ReperfusionKechun Chen, Bingtian Xu, Lu Long, et al.
Chemico-Biological Interactions|June 2, 2024
Phelligridimer A enhances the expression of mitofusin 2 and protects against cerebral ischemia/reperfusion injuryXing Li, Bingtian Xu, Lu Long, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|February 9, 2026
The Critical Role of Epithelial-Mesenchymal Transition (EMT) in Colorectal Cancer Progression and Therapeutic OutcomesHailang Jiang, Bingtian Xu
International Journal of Biological Sciences|November 13, 2018
Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic strokeHaitao Wang, Uma Gaur, Jiao Xiao, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 25, 2025
OAC1 improves mitofusin 2 expression to alleviate neuronal injury following experimental ischemic strokeYuanyuan Wang, Kechun Chen, Bingtian Xu, et al.
Glia|May 24, 2024
Inhibition of phosphodiesterase 4 attenuates aquaporin 4 expression and astrocyte swelling following cerebral ischemia/reperfusion injuryKechun Chen, Bingtian Xu, Shuqin Qiu, et al.
Free Radical Biology & Medicine|December 28, 2020
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathwayBingtian Xu, Jiangping Xu, Ningbo Cai, et al.
European Journal of Pharmacology|May 15, 2022
Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathwayNingbo Cai, Bingtian Xu, Xing Li, et al.
Cellular and Molecular Neurobiology|October 30, 2019
Inhibition of PDE4 Attenuates TNF-α-Triggered Cell Death Through Suppressing NF-κB and JNK Activation in HT-22 Neuronal CellsJiao Xiao, Rumeng Yao, Bingtian Xu, et al.
Cell Death and Differentiation|March 3, 2026
ACSL4-mediated astrocyte ferroptosis augments neuroinflammation and exacerbates NMOSD pathologyHaixia Wen, Yinyu Zi, Zhuhe Liu, et al.
Molecular Neurobiology|September 17, 2024
Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/ReperfusionKechun Chen, Bingtian Xu, Lu Long, et al.
Chemico-Biological Interactions|June 2, 2024
Phelligridimer A enhances the expression of mitofusin 2 and protects against cerebral ischemia/reperfusion injuryXing Li, Bingtian Xu, Lu Long, et al.
Pageof 2